Biogen (BIIB) PT Lowered to $300 at Goldman Sachs, Following Earnings

April 22, 2020 2:32 PM EDT Send to a Friend

Goldman Sachs analyst Terence Flynn ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Biogen (BIIB) PT Lowered to $300 at Goldman Sachs, Following Earnings

Member Login

Free News Feed